FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/01/016984 [Registered on: 08/01/2019] Trial Registered Prospectively
Last Modified On: 07/01/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Study to find out what will happen to blood glucose levels if glucose is added or not added to fluids given to chlildren below one year during operation 
Scientific Title of Study   Comparison of effect of Ringers lactate, with and without addition of dextrose, on intraoperativr blood glucose levels in infants 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sunil Rajan 
Designation  Professor 
Affiliation  Amrita Institute of Medical Sciences 
Address  Department of Anaesthesia Amrita Institute of Medical Sciences Kochi Kerala

Ernakulam
KERALA
682041
India 
Phone  9447464652  
Fax  04842802020  
Email  sunilrajan@aims.amrita.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sunil Rajan 
Designation  Professor 
Affiliation  Amrita Institute of Medical Sciences 
Address  Department of Anaesthesia Amrita Institute of Medical Sciences Kochi Kerala

Ernakulam
KERALA
682041
India 
Phone  9447464652  
Fax  04842802020  
Email  sunilrajan@aims.amrita.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Kaushik Barua 
Designation  MD resident 
Affiliation  Amrita Institute of Medical Sciences 
Address  Department of Anaesthesia Amrita Institute of Medical Sciences Kochi Kerala

Ernakulam
KERALA
682041
India 
Phone  8086028783  
Fax  04842802020  
Email  kaushikbarua13@gmail.com  
 
Source of Monetary or Material Support  
Amrita Institute of Medical Sciences, Ponekkara PO, Kochi 682041, Kerala, India 
 
Primary Sponsor  
Name  Amrita Institute of Medical Sciences 
Address  Amrita Institute of Medical Sciences Kochi 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sunil Rajan  Amrita Institute of Medical Sciences  Department of Anaesthesiology
Ernakulam
KERALA 
9447464652
04842802020
sunilrajan@aims.amrita.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: Q378||Unspecified cleft palate with bilateral cleft lip,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Dextrose  1% dextrose was added to Ringer lactate in one group and only Ringer lactate was used in other group 
 
Inclusion Criteria  
Age From  2.00 Month(s)
Age To  1.00 Year(s)
Gender  Both 
Details  Forty infants of American Society of Anesthesiologists (ASA) physical status 1 undergoing cheiloplasty and palatoplasty were recruited into the study 
 
ExclusionCriteria 
Details  Infants of diabetic mothers and those with endocrine disorders and anticipated difficult airway were excluded 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The primary objective of the present study is to evaluate the effect of addition of 1% dextrose to intra-operative maintenance fluids (Ringer’s lactate) on blood glucose levels in infants undergoing facial cleft surgeries.   After induction, then hourly intraoperatively for 2 hours 
 
Secondary Outcome  
Outcome  TimePoints 
The secondary objectives include assessment of development of hypoglycemia or hyperglycemia in these patients when intraoperative fluids were used with and without added dextrose.  After induction, then hourly intraoperatively for 2 hours 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   22/01/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   One group receives Ringer lactate intraoperatively and the other group receives Ringer lactate with 1% dextrose intraoperatively. Incidence of any hypoglycemia or hyperglycemia is noted in both groups.
 
Close